Table 1 Baseline background characteristics of the participants
From: Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction
Variable | Descriptive statistics |
|---|---|
Age (years), mean (SD) | 53.19 (12.73) |
BMI (kg/m²), mean (SD) | 27.65 (4.39) |
BMI Category, n (%) | |
Normal | 10 (27.8%) |
Overweight | 17 (47.2%) |
Obese | 9 (25%) |
Heart rate (bpm), mean (SD) | 86.3 (11.2) |
Systolic BP, mean (SD) | 121.4 (15.9) |
Diastolic BP, mean (SD) | 77.7 (9.3) |
Past medical history, n (%) | |
Diabetes mellitus | 4 (11.1%) |
Hypertension | 7 (19.4%) |
Hyperlipidemia | 8 (22.2) |
Coronary artery disease | 2 (5.6) |
Cancer details | |
Laterality of breast cancer, n (%) | |
Right breast | 14 (38.9%) |
Left breast | 22 (61.1%) |
Receptor status, n (%) | |
ER-Positive | 19 (52.8%) |
PR-Positive | 23 (63.9%) |
Presence of metastasis, n (%) | 6 (16.7%) |
Previous radiation therapy, n (%) | 28 (77.8%) |
Positive family history of breast cancer, n (%) | 15 (41.7%) |